Microbot Medical Inc. (MBOT)

Market Cap	212.91M
Revenue (ttm)	n/a
Net Income (ttm)	-12.71M
Shares Out	52.57M
EPS (ttm)	-0.50
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,089,467
Open	4.000
Previous Close	3.890
Day's Range	3.920 - 4.190
52-Week Range	0.850 - 4.670
Beta	1.22
Analysts	Strong Buy
Price Target	12.00 (+196.3%)
Earnings Date	Nov 12, 2025

About MBOT

Microbot Medical Inc., a clinical-stage medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space in Israel and the United States. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neu...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 20
• Stock Exchange: NASDAQ
• Ticker Symbol: MBOT
• Website: https://microbotmedical.com

Analyst Summary

According to one analyst, the rating for MBOT stock is "Strong Buy" and the 12-month stock price target is $12.0.

Price Target

$12.0

(196.30% upside)

Analyst Consensus: Strong Buy